TW222583B - - Google Patents

Info

Publication number
TW222583B
TW222583B TW082100297A TW82100297A TW222583B TW 222583 B TW222583 B TW 222583B TW 082100297 A TW082100297 A TW 082100297A TW 82100297 A TW82100297 A TW 82100297A TW 222583 B TW222583 B TW 222583B
Authority
TW
Taiwan
Application number
TW082100297A
Other languages
Chinese (zh)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of TW222583B publication Critical patent/TW222583B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW082100297A 1992-01-21 1993-01-18 TW222583B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82349592A 1992-01-21 1992-01-21

Publications (1)

Publication Number Publication Date
TW222583B true TW222583B (en:Method) 1994-04-21

Family

ID=25238929

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082100297A TW222583B (en:Method) 1992-01-21 1993-01-18

Country Status (10)

Country Link
EP (1) EP0556947A1 (en:Method)
JP (1) JPH0742231B2 (en:Method)
CN (1) CN1074606A (en:Method)
AU (1) AU3192393A (en:Method)
CA (1) CA2087510A1 (en:Method)
IL (1) IL104409A0 (en:Method)
MX (1) MX9300250A (en:Method)
TW (1) TW222583B (en:Method)
WO (1) WO1993013777A1 (en:Method)
ZA (2) ZA93374B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122522A (en) * 1989-06-21 1992-06-16 The Trustees Of The University Of Pennsylvania Treatment and control of ocular development
US6710051B1 (en) * 1997-01-06 2004-03-23 Klaus Trier Aps Screening method
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
WO2016171282A1 (ja) * 2015-04-24 2016-10-27 学校法人慶應義塾 近視予防剤及び近視進行抑制剤
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
US10845622B2 (en) 2015-09-15 2020-11-24 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
US12298602B2 (en) 2015-09-15 2025-05-13 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
CN110308570A (zh) 2015-09-15 2019-10-08 星欧光学股份有限公司 隐形眼镜产品
CN115414357B (zh) * 2022-08-30 2023-09-22 天津医科大学眼科医院 一种酰胺类化合物在制备防治近视的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212742B (it) * 1983-05-17 1989-11-30 Dompe Farmaceutici Spa Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica
ATE147626T1 (de) * 1989-06-21 1997-02-15 Univ Pennsylvania Verwendung von pirenzepine, telenzepine oder o- methoxy -sila-hexocyclium zur herstellung eines medikaments zur behandlung und regulierung der augenentwicklung

Also Published As

Publication number Publication date
CN1074606A (zh) 1993-07-28
CA2087510A1 (en) 1993-07-22
EP0556947A1 (en) 1993-08-25
JPH06206820A (ja) 1994-07-26
ZA93384B (en) 1993-08-23
JPH0742231B2 (ja) 1995-05-10
ZA93374B (en) 1993-08-23
WO1993013777A1 (en) 1993-07-22
IL104409A0 (en) 1993-05-13
MX9300250A (es) 1993-07-01
AU3192393A (en) 1993-07-22

Similar Documents

Publication Publication Date Title
DK0634000T3 (en:Method)
DK0603481T3 (en:Method)
MX186144B (en:Method)
TW228569B (en:Method)
TW235990B (en:Method)
TW222583B (en:Method)
FR2688028B1 (en:Method)
TW263536B (en:Method)
DK0648175T3 (en:Method)
TW253996B (en:Method)
FR2686323B1 (en:Method)
TW225083B (en:Method)
AU632452B2 (en:Method)
BRPI9204323A2 (en:Method)
IN174259B (en:Method)
IN177953B (en:Method)
IN185265B (en:Method)
ECSDI920001S (en:Method)
IN185566B (en:Method)
IN186902B (en:Method)
ITOR920002V0 (en:Method)
AU2281492A (en:Method)
AU639404B1 (en:Method)
AU2527592A (en:Method)
AU2619992A (en:Method)